Finance

Lists
300181:SHE
Zhejiang Jolly Pharmaceutical Co Ltd
CNÂ¥13.65
-1.30%
(-0.18) 1D
Aug 31, 3:04:19 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300181...
Open
CNÂ¥13.78
High
CNÂ¥13.82
Low
CNÂ¥13.59
Mkt. cap
9.70B
Avg. vol.
24.15M
Volume
12.91M
Dividend
2.56%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
May 28, 2026
P/E ratio
14.62
52-wk high
CNÂ¥19.42
52-wk low
CNÂ¥12.30
EPS
CNÂ¥0.93
Shares outstanding
701.39M
No. of employees
3K
Open
CNÂ¥13.78
High
CNÂ¥13.82
Low
CNÂ¥13.59
Mkt. cap
9.70B
Avg. vol.
24.15M
Volume
12.91M
Dividend
2.56%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
May 28, 2026
P/E ratio
14.62
52-wk high
CNÂ¥19.42
52-wk low
CNÂ¥12.30
EPS
CNÂ¥0.93
Shares outstanding
701.39M
No. of employees
3K
About Zhejiang Jolly Pharmaceutical Co Ltd
CEO-
Employees2.86K
Founded1995
Headquarters-
SectorPharmaceutical industry
Websitezuoli.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
680.26M
761.05M
897.80M
866.34M
Cost of goods sold
270.73M
312.62M
324.69M
334.66M
Cost of revenue
270.73M
312.62M
324.69M
334.66M
Research and development expenses
16.58M
27.59M
10.62M
12.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
236.27M
306.06M
329.11M
314.16M
Operating expense
231.44M
327.68M
328.51M
308.79M
Total operating expenses
502.17M
640.30M
653.20M
643.45M
Operating income
178.09M
120.75M
244.60M
222.89M
Other non operating income
-6.86M
6.88M
-37.17K
-14.45M
EBT including unusual items
162.87M
144.91M
237.61M
209.06M
EBT excluding unusual items
168.22M
124.44M
241.07M
211.93M
Income tax expense
23.95M
20.58M
35.60M
31.81M
Effective tax rate
14.70%
14.20%
14.98%
15.22%
Other operating expenses
-24.00M
-2.37M
-17.70M
-10.93M
Net income
136.47M
121.96M
199.59M
175.34M
Net profit margin
20.06%
16.03%
22.23%
-
Earnings per share
-
-
-
-
Interest and investment income
947.01K
633.16K
640.44K
4.13M
Interest expense
-3.96M
-3.82M
-4.13M
-640.44K
Net interest expenses
-3.01M
-3.19M
-3.49M
3.49M
Depreciation and amortization charges
-
-
-
-
EBITDA
194.89M
139.48M
263.33M
249.37M
Gain or loss from assets sale
-23.17K
-591.24K
-
172.62K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps